imatinib mesylate has been researched along with Soft Tissue Infections in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hirabayashi, K; Minagawa, A; Morita, D; Nakazawa, H; Nakazawa, Y; Okura, E; Saito, S; Tanaka, M; Uchida, E | 1 |
1 other study(ies) available for imatinib mesylate and Soft Tissue Infections
| Article | Year |
|---|---|
Skin and soft tissue infections in adolescent chronic myeloid leukemia under dasatinib treatment.
Topics: Adolescent; Adult; Dasatinib; Humans; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Protein Kinase Inhibitors; Pyrimidines; Retrospective Studies; Soft Tissue Infections | 2022 |